Mental and behavioural disorders due to use of cocaine
Conditions
Interventions
60 patients will be randomly allocated to treatment sequence A: 6 weeks of homeopathy,
followed by six weeks of placebo.
60 patients will be randomly allocated to treatment sequence B: 6 weeks of pla
Drug
Sponsors
Prefeitura do Município de Itajaí
Universidade do Vale do Itajaí
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Assist score for cocaine between 4 and 26.
Exclusion criteria
Exclusion criteria: Negative urinary benzoilecgonine detection (< 150 ng/mL).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| During homeopathic treatment and comparing to placebo we expect to find a 12% reduction of the reported number of cocaine using days (registered by means of a timeline follow-back methodology). ;- | — |
Secondary
| Measure | Time frame |
|---|---|
| During homeopathic treatment and comparing to placebo we expect to find (assessed by Minnesota Cocaine Craving Scale): a lower percentage of positive benzoylecgonine samples; reduction in cocaine craving; reduction in daily craving episodes number; reduction in craving episodes mean duration; a greater patient perception of medication action favoring craving reduction. We expect to achieve treatment adherence greater than 50%. We also expect to find no significative difference between the percentage of Adverse Events during homeopathy or placebo use. | — |
Countries
Brazil
Contacts
Public ContactUbiratan Adler
Unidade de Saúde Escola da Universidade Federal de São Carlos
Outcome results
None listed